FDA warning letter to
DFI Co., Ltd.
CGMP/QSR/Medical Devices/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.
DFI Co., Ltd.'s FDA history
Recalls in the last 12 months
| May 13 | Class II | DFI Co., Ltd. Device |
One Step K in vitro diagnostic test REF: 81A4 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
Uric Acid in vitro diagnostic test REF: 31H0P The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step P in vitro diagnostic test REF: 8194 The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step pH in vitro diagnostic test REF: 31I4P The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step 10A in vitro diagnostic test The devices were distributed without required FDA premarket clearance or approval. |
| May 13 | Class II | DFI Co., Ltd. Device |
One Step UTI in vitro diagnostic test REF: 3374 The devices were distributed without required FDA premarket clearance or approval. |